About 15 percent of the population in the United States has diabetes, which is considered a major risk factor for heart disease. Robert Gerszten, MD, director of clinical and translational research at the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, discusses his new study that identifies a biomarker that can predict diabetes risk up to 10 years before the onset of the disease. Dr. Gerszten explains that by using this new technique in the future, physicians may be able to identify patients who have the disease, allowing them to live healthier lives. Watch Dr. Gerszten discuss the study and what it means for patients.

Robert Gerszten is interviewed in THE WEIGHT OF THE NATION, a four-part HBO documentary series, featuring case studies, interviews with our nation’s leading experts, and individuals and their families struggling with obesity. You can find him in Part 2 (Choices) starting around 32 minutes into the episode, talking about exercise and weight loss.

Proto Magazine discusses Gerszten Lab’s publication on “Metabolic Signatures of Exercise in Human Plasma” and its implications.

The study of metabolites does an end run around genomics to provide telling clues to your future health.

Robert Gerszten is interviewed about his publication, “Metabolic signatures of exercise in human plasma.”